Literature DB >> 9799753

Cardiac troponin I and minor cardiac damage: biochemical markers in a clinical model of myocardial lesions.

J M del Rey1, A H Madrid, J M Valiño, J Rubí, J Mercader, C Moro, E Ripoll.   

Abstract

Radiofrequency (RF) catheter ablation is the curative treatment of choice for many cardiac arrhythmias. After RF ablation there is always a small localized endomyocardial necrosis, necessary to abolish the arrhythmia. We designed this study to determine the serum concentrations of several cardiac markers in patients who underwent RF catheter ablation. The study shows a higher frequency of increase of serum cardiac troponin I (cTnI) than of creatine kinase (CK), the CK MB isoenzyme (CK-MB), or myoglobin. A pathological value of cTnI was found in 47 of 51 patients (92%) in the ablation group. The area under the ROC curve for cTnI was 0.9375, significantly higher than for the other biochemical markers (0.86, 0.76, and 0.75 for CK-MB, myoglobin, and CK, respectively), with P <0.05. We conclude that the serum concentration of cTnI is the best biochemical marker for detecting the minor myocardial damage produced by RF ablation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9799753

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  3 in total

1.  High titres of serum antinuclear antibodies, mostly directed against nucleolar antigens, are associated with the presence of coronary atherosclerosis.

Authors:  D J Grainger; H W L Bethell
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

2.  Prediction of mid-term outcome after cryo-balloon ablation of atrial fibrillation using post-procedure high-sensitivity troponin level.

Authors:  Tolga Aksu; Sukriye Ebru Golcuk; Tümer Erdem Guler; Kivanç Yalin; Ismail Erden
Journal:  Cardiovasc J Afr       Date:  2015-03-17       Impact factor: 1.167

3.  Magnesium decreases cardiac injury in patients undergoing coronary artery bypass surgery.

Authors:  Adem Grbolar Resatoglu; Orhan Saim Demirturk; Nuran Yener; Ali Yener
Journal:  Ann Saudi Med       Date:  2004 Jul-Aug       Impact factor: 1.526

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.